文献速递造血干细胞移植与细胞治疗

供者T细胞来源GM-CSF驱动胃肠道树突细胞呈递同种抗原

Donor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract.
PubMed 文献 · Blood Adv · 2019-01-01

该研究利用IL-17A命运报告系统、转录分析和同种抗原呈递实验,探究异基因干细胞移植后分泌GM-CSF的T细胞来源及其对APC功能的影响。发现供者T细胞来源GM-CSF扩增结肠和淋巴结中呈递同种抗原的供者树突细胞,后者在肠系膜淋巴结致敏供者T细胞并放大结肠急性GVHD。

要点

  • 供者T细胞来源GM-CSF扩增结肠和淋巴结中同种抗原呈递树突细胞。
  • 肠系膜淋巴结中GM-CSF依赖性树突细胞致敏供者T细胞并放大结肠急性GVHD。
  • 抑制GM-CSF可能限制供者同种抗原呈递和下消化道GVHD。

核心结论

  • 供者T细胞来源GM-CSF驱动结肠同种抗原呈递并放大急性GVHD严重程度。
  • GM-CSF抑制可能是限制下消化道供者同种抗原呈递和GVHD的可行临床干预。

研究设计与样本

  • 实验性异基因干细胞移植研究,使用IL-17A命运报告系统、转录分析和同种抗原呈递实验。

主要发现

  • 移植后结肠中分泌GM-CSF的Th17和非Th17细胞随时间扩增,4周时Th17谱系占该部位分泌GM-CSF T细胞的10%至20%。
  • 供者T细胞来源GM-CSF扩增结肠和淋巴结中呈递同种抗原的供者树突细胞。
  • 肠系膜淋巴结中GM-CSF依赖性树突细胞致敏供者T细胞并放大结肠急性GVHD。

临床怎么用

  • 抑制GM-CSF可能作为限制供者同种抗原呈递和下消化道GVHD的临床干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Granulocyte-macrophage colony-stimulating factor (GM-CSF) has recently emerged as an important pathogenic cytokine in acute graft-versus-host disease (GVHD), but the nature of the T-cell lineages secreting the cytokine and the mechanisms of action are less clear. Here we used interleukin 17A-fate reporter systems with transcriptional analysis and assays of alloantigen presentation to interrogate the origins of GM-CSF-secreting T cells and the effects of the cytokine on antigen-presenting cell (APC) function after experimental allogeneic stem cell transplantation (SCT). We demonstrated that although GM-CSF-secreting Th17 and non-Th17 cells expanded in the colon over time after SCT, the Th17 lineage expanded to represent 10% to 20% of the GM-CSF secreting T cells at this site by 4 weeks. Donor T-cell-derived GM-CSF expanded alloantigen-presenting donor dendritic cells (DCs) in the colon and lymph nodes. In the mesenteric lymph nodes, GM-CSF-dependent DCs primed donor T cells and amplified acute GVHD in the colon. We thus describe a feed-forward cascade whereby GM-CSF-secreting donor T cells accumulate and drive alloantigen presentation in the colon to amplify GVHD severity. GM-CSF inhibition may be a tractable clinical intervention to limit donor alloantigen presentation and GVHD in the lower gastrointestinal tract.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Gartlan KH, Koyama M, Lineburg KE, et al. Donor T-cell-derived GM-CSF drives alloantigen presentation by dendritic cells in the gastrointestinal tract. Blood Adv. 2019. PMID: 31585949. doi:10.1182/bloodadvances.2019000053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。